2-6865636-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207315.4(CMPK2):āc.61G>Cā(p.Gly21Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,355,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_207315.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMPK2 | NM_207315.4 | c.61G>C | p.Gly21Arg | missense_variant | 1/5 | ENST00000256722.10 | NP_997198.2 | |
CMPK2 | NM_001256477.1 | c.61G>C | p.Gly21Arg | missense_variant | 1/4 | NP_001243406.1 | ||
CMPK2 | NM_001256478.1 | c.61G>C | p.Gly21Arg | missense_variant | 1/4 | NP_001243407.1 | ||
CMPK2 | NR_046236.2 | n.210+790G>C | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151816Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000295 AC: 9AN: 30554Hom.: 0 AF XY: 0.000268 AC XY: 5AN XY: 18634
GnomAD4 exome AF: 0.000135 AC: 162AN: 1203852Hom.: 0 Cov.: 38 AF XY: 0.000127 AC XY: 75AN XY: 588672
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151922Hom.: 0 Cov.: 35 AF XY: 0.000121 AC XY: 9AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2024 | The c.61G>C (p.G21R) alteration is located in exon 1 (coding exon 1) of the CMPK2 gene. This alteration results from a G to C substitution at nucleotide position 61, causing the glycine (G) at amino acid position 21 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at